文献速递乳腺癌放疗放疗物理与技术

电子患者报告结局减少乳腺癌放疗后随访就诊的实施评估

Assessing the Implementation of Electronic Patient-Reported Outcomes (ePRO) to Reduce Follow-up Visits for Patients Undergoing Radiation Therapy for Breast Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-09-28

本研究在学术癌症中心对46例乳腺癌放疗患者每周实施电子患者报告结局(ePRO)评估,治疗结束6周后对症状不超过中度的患者提供取消常规随访的选择。结果显示78%选择保留预约、15%取消、6.5%不确定;基于ePRO的策略可行且合适,但接受度约20%。

要点

  • ePRO每周评估乳腺癌放疗毒性,6周后症状≤中度者可选择取消随访。
  • 78%患者选择保留预约,仅15%取消,6.5%不确定。

核心结论

  • 基于ePRO告知放疗后随访就诊的策略在完成乳腺放疗且症状轻至中度的患者中可行且合适。
  • 尽管接受度低(约20%),乳腺癌高患病率下该策略仍可能减少低价值就诊的临床负担。

研究设计与样本

  • 在学术癌症中心对接受乳腺癌放疗的患者每周实施ePRO工具评估。
  • 治疗结束6周后,对症状不超过中度的患者提供取消常规放疗后随访就诊的选项。
  • 从电子健康记录收集临床和人口学数据,共46例患者回答了预约取消问题(中位年龄60岁)。

主要发现

  • 46例回答者中32例(70%)为白人,5例(11%)黑人,5例(11%)亚裔,2例(4.3%)西班牙裔。
  • 36例(78%)选择保留预约,7例(15%)选择取消,3例(6.5%)不确定。
  • 取消或不确定者与保留预约者在年龄、种族、民族、BMI和到中心距离上相似,但报告的症状更少。
  • 取消随访者6个月内住院更少(0 vs 2 [5.6%]),急诊就诊相当(8.6% vs 10%)。

关键数值与推荐

  • ePRO工具每周评估放疗毒性(乳腺增大/压痛、皮肤改变、疼痛、疲劳)采用PRO-CTCAE,焦虑采用GAD-2筛查工具。
  • 症状严重度采用5点Likert量表(无至非常严重)。
  • 治疗结束6周后,症状不超过中度的患者可取消常规放疗后随访就诊。

临床怎么用

  • 对完成乳腺放疗且ePRO报告症状轻至中度的患者,可提供取消常规随访就诊的选项。
  • 实施时需注意患者接受度较低(约20%选择取消或不确定),多数患者仍倾向保留预约。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We aimed to evaluate the acceptability, appropriateness, and feasibility of using an electronic patient-reported outcome (ePRO)-based strategy to reduce postradiation therapy (RT) visits in patients with breast cancer who reported minimal symptoms. METHODS AND MATERIALS: An ePRO instrument was administrated weekly for patients undergoing RT for breast cancer at an academic cancer center. The instrument assessed RT toxicities (breast enlargement/tenderness, skin changes, pain, and fatigue) using Patient-Reported Outcomes National Cancer Institute Common Terminology Criteria for Adverse Events and anxiety with the Generalized Anxiety Disorder 2-item screening tool. Patients rated symptom severity on a 5-point Likert scale (none to very severe). Six weeks after treatment completion, patients with no more than moderate symptoms were offered the option to cancel their routine post-RT follow-up visit. Clinical and demographic data were collected from electronic health records. RESULTS: Among the 46 patients (median age: 60 years) who responded to the appointment cancellation question, 32 (70%) were White, 5 (11%) Black, 5 (11%) Asian, and 2 (4.3%) Hispanic. Regarding acceptability among respondents, we found 36 (78%) chose to keep their appointments, 7 (15%) opted to cancel, and 3 (6.5%) were not sure. In terms of appropriateness, patients who canceled or were unsure were similar in age, race, ethnicity, body mass index, and travel distance to the center, but reported fewer symptoms than those who kept their appointments, with significantly lower breast tenderness (10% vs 50%, respectively, P = .026), and a trend toward lower pain in the radiated area (30% vs 61%, P = .073) and fatigue (30% vs 56%, P = .23). As an assessment of feasibility, fewer hospitalizations within 6 months occurred among those cancelling their follow-up visit (0 vs 2 [5.6%]), whereas urgent care visits were comparable (8.6% vs 10%). CONCLUSIONS: An ePRO-based strategy to inform post-RT follow-up visits appears feasible and appropriate for patients who completed breast RT with mild-to-moderate symptoms. Despite low acceptability (∼20%), the high prevalence of breast cancer suggests this strategy could still reduce the clinical burden of low-value visits.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Teles MS, Lapen K, Huang J, et al. Assessing the Implementation of Electronic Patient-Reported Outcomes (ePRO) to Reduce Follow-up Visits for Patients Undergoing Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2025. PMID: 41027545. doi:10.1016/j.ijrobp.2025.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。